| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 0,026 | 0,034 | 17:27 |
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mi | Glow Lifetech reports FY25 results; revenue rises +144% Y/Y | 5 | Seeking Alpha | ||
| Mi | Glow Lifetech Corp.: Glow Lifetech Reports Fourth Quarter and Full Year 2025 Financial Results; 146% YoY Revenue Growth and Second Consecutive Quarter of Positive Cash Flow | 286 | Newsfile | Toronto, Ontario--(Newsfile Corp. - April 8, 2026) - Glow Lifetech Corp. (CSE: GLOW) (OTCID: GLWLF) (FSE: 9DO) ("Glow" or the "Company") is pleased to report its financial results for the fourth... ► Artikel lesen | |
| 27.03. | Glow Lifetech Corp: Glow Lifetech reduces warrants, stock options in Q1 | 2 | Stockwatch | ||
| 27.03. | Glow Lifetech reduces over 41M warrants, 5M options | 3 | Seeking Alpha | ||
| GLOW LIFETECH Aktie jetzt für 0€ handeln | |||||
| 27.03. | Glow Lifetech Corp.: Glow Lifetech Reduces Over 41 Million Warrants and 5 Million Options, Strengthening Capital Structure; All $0.05 Warrants Now Expired | 361 | Newsfile | Toronto, Ontario--(Newsfile Corp. - March 27, 2026) - Glow Lifetech Corp. (CSE: GLOW) (OTCID: GLWLF) (FSE: 9DO) ("Glow" or the "Company") is pleased to announce a significant reduction in its outstanding... ► Artikel lesen | |
| 03.02. | Glow Lifetech Corp: Glow Lifetech begins offering MOD, .decimal in Manitoba | 4 | Stockwatch | ||
| 03.02. | Glow Lifetech Corp.: Glow Lifetech Announces Expansion into Manitoba Market and Portfolio Expansion in New Brunswick, Advancing National Growth Strategy | 439 | Newsfile | Toronto, Ontario--(Newsfile Corp. - February 3, 2026) - Glow Lifetech Corp. (CSE: GLOW) (OTCID: GLWLF) (FSE: 9DO) ("Glow" or the "Company") is pleased to announce the expansion of its MOD and .decimal... ► Artikel lesen | |
| 07.01. | Glow Lifetech Corp: Glow Lifetech lists MOD, .decimal products on Mendo | 3 | Stockwatch | ||
| 07.01. | Glow Lifetech Corp.: Glow Lifetech Expands into Medical Cannabis Channel with National Launch on Mendo Medical | 349 | Newsfile | Toronto, Ontario--(Newsfile Corp. - January 7, 2026) - Glow Lifetech Corp. (CSE: GLOW) (OTCID: GLWLF) (FSE: 9DO) ("Glow" or the "Company") is pleased to announce the launch of its MOD and .decimal... ► Artikel lesen | |
| 25.11.25 | Glow Lifetech Corp: Glow Lifetech has EBITDA loss of $28,004 in Q3 2025 | 6 | Stockwatch | ||
| 25.11.25 | Glow Lifetech Corp.: Glow Lifetech Reports Record Q3 2025 Financial Results; 193% YoY Revenue Growth and Achieves First Positive Cash Flow from Operations | 511 | Newsfile | Toronto, Ontario--(Newsfile Corp. - November 25, 2025) - Glow Lifetech Corp. (CSE: GLOW) (OTCID: GLWLF) (FSE: 9DO) ("Glow" or the "Company") is pleased to report its financial results for the third... ► Artikel lesen | |
| 19.11.25 | Glow Lifetech Corp.: Glow Lifetech Achieves Debt-Free Status, Strengthening Balance Sheet and Enhancing Financial Flexibility for Growth | 566 | Newsfile | Toronto, Ontario--(Newsfile Corp. - November 19, 2025) - Glow Lifetech Corp. (CSE: GLOW) (OTCID: GLWLF) (FSE: 9DO) ("Glow" or the "Company") is pleased to announce that it has achieved debt-free status... ► Artikel lesen | |
| 28.10.25 | Glow Lifetech Corp: Glow Lifetech receives $452,500 from warrant exercise | 4 | Stockwatch | ||
| 28.10.25 | Glow Lifetech Corp.: Glow Lifetech Reduces Warrant Overhang by 20+ Million as Largest Shareholder Exercises $450k+ At-the-Money Warrants, Bolstering Balance Sheet | 446 | Newsfile | Toronto, Ontario--(Newsfile Corp. - October 28, 2025) - Glow Lifetech Corp. (CSE: GLOW) (OTCID: GLWLF) (FSE: 9DO) ("Glow" or the "Company") is pleased to announce that it has further strengthened its... ► Artikel lesen | |
| 24.10.25 | Glow Lifetech Corp: Glow Lifetech investor Nova acquires 9.05M shares | 17 | Stockwatch | ||
| 23.10.25 | Nova Capital Trading Limited: Nova Capital Trading Announces Filing of Early Warning Report Related to Exercise of Warrants in the Capital of Glow Lifetech | 386 | Newsfile | Toronto, Ontario--(Newsfile Corp. - October 23, 2025) - Nova Capital Trading Limited (the "Acquiror") announces that it has filed an early warning report (the "Report") announcing the acquisition (the... ► Artikel lesen | |
| 21.10.25 | Glow Lifetech Corp: Glow Lifetech makes first shipment to Saskatchewan | 14 | Stockwatch | ||
| 20.10.25 | Glow Lifetech Corp.: Glow Lifetech Provides Commercial & Corporate Update; Launches New Key Accounts, Advances National Expansion | 707 | Newsfile | Toronto, Ontario--(Newsfile Corp. - October 20, 2025) - Glow Lifetech Corp. (CSE: GLOW) (OTCID: GLWLF) (FSE: 9DO) ("Glow" or the "Company") is pleased to provide a commercial update highlighting new... ► Artikel lesen | |
| 24.09.25 | Glow Lifetech to Present at the Annual Smallcap Discoveries Conference in Vancouver | 455 | Newsfile | Toronto, Ontario--(Newsfile Corp. - September 24, 2025) - Glow Lifetech Corp. (CSE: GLOW) (OTCID: GLWLF) (FSE: 9DO) ("Glow" or the "Company") is pleased to announce the company is participating in... ► Artikel lesen | |
| 16.09.25 | Glow Lifetech Corp.: Glow Lifetech Expands MOD and .decimal brands in Saskatchewan Market, Advancing National Growth Strategy | 538 | Newsfile | Toronto, Ontario--(Newsfile Corp. - September 16, 2025) - Glow Lifetech Corp. (CSE: GLOW) (OTCQB: GLWLF) (FSE: 9DO) ("Glow" or the "Company") is pleased to announce the expansion of its MOD and .decimal... ► Artikel lesen |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| BIONTECH | 84,20 | +2,37 % | Biotech-Werte im Check: Warum Bioxyne, Newron und BioNTech jetzt auf Substanz statt Hoffnung setzen | ||
| EVOTEC | 5,295 | +12,66 % | Evotec: Aktivistischer Investor macht Druck - die Hintergründe | Die Aktie des Hamburger Wirkstoffforschers Evotec hat den Anlegern in den zurückliegenden Jahren nur wenig Freude bereitet. Der Titel rutschte sogar vor kurzem auf ein neues Mehrjahrestief ab. Das ruft... ► Artikel lesen | |
| BB BIOTECH | 50,20 | -0,59 % | Dividenden als Portfolio-Anker: Alte Bekannte Sanofi und BB Biotech - Geheimtipp RE Royalties | In einem Marktumfeld, das von strukturellen Umbrüchen geprägt ist, rückt die Stabilität des Portfolios in den Fokus. Analysten von J.P. Morgan betonen, dass der Schutz von Buchgewinnen der vergangenen... ► Artikel lesen | |
| MEDIGENE | 0,024 | -20,92 % | Medigene: Zurückziehung - 18.11.2025 | ||
| QIAGEN | 35,760 | +1,16 % | BARCLAYS stuft QIAGEN NV auf 'Equal Weight' | LONDON (dpa-AFX Analyser) - Die britische Investmentbank Barclays hat das Kursziel für Qiagen von 58 auf 44 Dollar gesenkt, aber die Aktie von "Overweight" auf "Equal Weight" abgestuft. Eine Übernahme... ► Artikel lesen | |
| MODERNA | 44,585 | +3,45 % | Moderna, Inc.: Moderna to Present Revaccination Data for Its Investigational Seasonal Influenza Vaccine and for mRESVIA at ESCMID 2026 | CAMBRIDGE, MA / ACCESS Newswire / April 6, 2026 / Moderna, Inc. (NASDAQ:MRNA) today announced that the Company will present late-breaking oral presentations on revaccination data for both mRNA-1010... ► Artikel lesen | |
| PAION | 0,078 | +23,81 % | XFRA MISTRADE ANTRAG IN ISIN DE000A3E5EG5 WURDE STATTGEGEBEN | Dem Mistrade-Antrag wurde stattgegeben. Folgende Geschaefte in der ISIN DE000A3E5EG5, Wertpapier-Name: PAION AG INH O.N., wurden aufgehoben:ISIN Datum Zeit Volumen PreisDE000A3E5EG5 02.02.2026 08:13:40 300 0... ► Artikel lesen | |
| VALNEVA | 2,660 | +0,53 % | EILMELDUNG bei Valneva: Das Signal das die meisten Anleger noch nicht kennen - Was ich konkret unternommen habe | ||
| AMGEN | 296,80 | -0,22 % | BeOne wins China approval for Amgen's lung cancer drug Imdelltra | ||
| EPIGENOMICS | 0,920 | 0,00 % | PTA-AFR: Epigenomics AG: Vorabbekanntmachung über die Veröffentlichung von Finanzberichten gemäß §§ 114-117 WpHG | DJ PTA-AFR: Epigenomics AG: Vorabbekanntmachung über die Veröffentlichung von Finanzberichten gemäß §§ 114-117 WpHG
Vorabbekanntmachung Finanzberichte gemäß ---- 114-117 WpHG
Epigenomics... ► Artikel lesen | |
| NOVAVAX | 6,900 | +0,15 % | Activist investor revives campaign to overhaul Novavax board | ||
| STRYKER | 296,80 | +0,51 % | Stryker To Buy Amplitude Vascular Systems | WASHINGTON (dpa-AFX) - Stryker Corporation (SYK), a medical technology company, said on Monday that it has signed a deal to buy Amplitude Vascular Systems, Inc., a privately held developer of... ► Artikel lesen | |
| BIOGEN | 152,42 | +1,59 % | Biogen to acquire Apellis in $5.6bn deal | ||
| BIOFRONTERA | 2,630 | +2,73 % | BIOFRONTERA AG im Abwärtsmodus - ruhige Einordnung | ||
| HEIDELBERG PHARMA | 2,780 | +2,58 % | EQS-Adhoc: Heidelberg Pharma AG: Heidelberg Pharma legt Dosis für Phase II-Studie (RP2D) mit dem ADC-Kandidaten HDP-101 fest | EQS-Ad-hoc: Heidelberg Pharma AG / Schlagwort(e): Sonstiges
Heidelberg Pharma AG: Heidelberg Pharma legt Dosis für Phase II-Studie (RP2D) mit dem ADC-Kandidaten HDP-101 fest
09.04.2026... ► Artikel lesen |